Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Impact of the Association between Tgl and EZH2 Mutations (Y641N/Y641F/Y641H/Y641S) on Disease Free Survival of Patients with Diffuse Large B-Cell Lymphoma

Myrna Candelaria, MD PharmD, Adriana Palacios Campos, MD, Olga Gutierrez Hernandez, QFB, Alejandro Aviles, MD, Uvi Cancino-Ramos, MD, Lucia Taja Chayeb, PhD, Osvaldo García-Perez, MD, David Cantú de León

Blood (2019) 134 (Supplement_1): 5222.

https://doi.org/10.1182/blood-2019-125906

Published: 2019

Journal Articles

18F-Fluorodeoxyglucose Positron Emission Tomography Versus Bone Marrow Biopsy for the Evaluation of Bone Marrow Infiltration in Newly Diagnosed Lymphoma Patients: Real-World Clinical Management of Patients at the National Cancer Institute, México

Tania Aguado, MD, Antonio Olivas-Martinez, MD, Uvi Cancino-Ramos, MD, Diego Zúñiga, MD, Carmen Lome, MD, Silvia Rivas-Vera, MD, Myrna Candelaria, MD PharmD

Blood (2019) 134 (Supplement_1): 5813.

https://doi.org/10.1182/blood-2019-126231

Published: 2019

Journal Articles

Report of 5 Cases of Extramedullary Myeloma with Central Nervous System Involvement Treated with a Combination of Carfilzomib/Thalidomide/Dexamethasone As a First Line Treatment at a Single Institution in Mexico

Ramiro Espinoza, MD, Diana Berenice Nolasco, MD, Sosa Alejandro, MD, Zapata Nidia, MD, Cervera Eduardo, MD, Myrna Candelaria, MD PhD, Alarcon Silvia, MD, Espinoza Vicente, MD, Vieyra Magnolia, MD, Gutierrez Jorge, MD, Luis Sosa, MD, Escobedo Maria, LPN, Gonzalez Reynaldo, CHEM, Oñate Luis, MD PhD, Lahuerta Juan, MD, Labardini Juan, MD

Blood (2016) 128 (22): 5704.

https://doi.org/10.1182/blood.V128.22.5704.5704

Published: 2016

Journal Articles

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Ramiro Espinoza, MD, Manuel Aguilar Rodríguez, MD, Nidia P. Zapata, MD, Jorge Carlos Torres, Sr., Resident, Diana Berenice Nolasco, MD, Silvia Eugenia Alarcon Barrios, Eduardo Cervera, Myrna Candelaria, MD PhD, Valentin Lozano, Alejandro Sosa, Javier Espinoza, Magnolia Vieyra, Jorge Gutierrez, Luis Mario Sosa, Reynaldo González, Luis Oñate, Juan Labardini

Blood (2016) 128 (22): 5362.

https://doi.org/10.1182/blood.V128.22.5362.5362

Published: 2016

Journal Articles

Local Experience with Autologous Stem Cell Transplant in Multiple Myeloma at a Public Institution (Instituto Nacional de Cancerologia)

Eduardo Cervera, Jorge Carlos Torres, Sr., Nidia P. Zapata, MD, Juan Rafael Labardini, Sr., Hematologist, Jose Ramiro Espinoza, Hematologist, Magnolia Vieyra, MD, Antonio Sosa, Valentin Lozano, MD, Myrna Candelaria, MD PhD, Abelardo Meneses, MD

Blood (2015) 126 (23): 5504.

https://doi.org/10.1182/blood.V126.23.5504.5504

Published: 2015

Journal Articles

Impact Of a Federal Program On response Rate & Survival, In a Cohort Of Patients With Diffuse Large B- Cell Lymphoma. Analysis In a Single National Reference Institution In Mexico

Myrna Candelaria, MD, PhD, Juan Labardini, MD, PhD, Ana Florencia Ramirez, Alejandro Aviles, MD, Enrique Estrada-Lobato, MD, Abelardo Meneses-Garcia, Md, PhD, Alejandro Mohar, MD, PhD

Blood (2013) 122 (21): 5608.

https://doi.org/10.1182/blood.V122.21.5608.5608

Published: 2013

Journal Articles

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Rafael Hurtado, MD, Jose Pablo Vargas Viveros, MD, Carrillo Muñoz Silvia, RN, Judith Cruz-Velazquez, Myrna Candelaria, MD, PhD, Eduardo Cervera, MD

Blood (2012) 120 (21): 1689.

https://doi.org/10.1182/blood.V120.21.1689.1689

Published: 2012

Journal Articles

Hydralazine + Magnesium Valproate as Epigenetic Treatment for Myelodysplastic Syndrome (MDS). Preliminary Results of a Phase II Trial.

Myrna Candelaria, MD, Aquileo Herrera, MD, Juan Labardini, Sr., MD, Aurora Gonzalez-Fierro, Biol, Catalina Trejo-Becerril, MC, Erick de la Cruz-Hernandez, Dr, Brenda A la Torre-Talavera, Biol, Alfonso Duenas-Gonzalez, DR

Blood (2009) 114 (22): 1767.

https://doi.org/10.1182/blood.V114.22.1767.1767

Published: 2009

Journal Articles

The Age of Mexican Patients with Chronic Myeloid Leukemia (CML) Ph+ Is Quite Younger Than the Reported in USA and European Series.

Pablo Vargas-Viveros, M.D., Rafael Hurtado Monroy, MD, Eduardo Cervera, MD, Carlos Best, M.D., Alvaro Aguayo, M.D., Myrna Candelaria, MD

Blood (2009) 114 (22): 4291.

https://doi.org/10.1182/blood.V114.22.4291.4291

Published: 2009

Journal Articles

Importance of the Polymorphisms of the Thiopurine S-Methyltransferase Gene (TMPT) Determination in Mexican Mestizo Patients with Acute Lymphoblastic Leukemia (ALL).

Myrna Candelaria, MD, Lucia Taja-Chayeb, PhD, Silvia Vidal, MD, Olga Gutierrez, MD, Alfonso Dueñas-Gonzalez, PhD

Blood (2007) 110 (11): 4222.

https://doi.org/10.1182/blood.V110.11.4222.4222

Published: 2007

Journal Articles

Imatinib Alone (IA) Vs. Imatinib + Ara-C (IMAC): A Randomized Phase III Clinical Trial for the Treatment of Early Phase (EP) Chronic Myeloid Leukemia (CML) Ph+. Preliminary Report of Mexican Cooperative Leukemia Group (GRUMELA).

Rafael Hurtado Monroy, MD, Pablo Vargas-Viveros, MD, Eduardo Cervera, MD, Myrna Candelaria, MD, Alvaro Aguayo, MD, Emma Gallardo, MD, Eucario Leon, MD, Juan Labardini, MD, Ricardo Sosa, MD, Rogelio Paredes, MD, Fernando Romero, MD, Oscar Perez, MD, Omar Coronel-Ayala, MD

Blood (2004) 104 (11): 1015.

https://doi.org/10.1182/blood.V104.11.1015.1015

Published: 2004

NARROW

Impact of the Association between Tgl and EZH2 Mutations (Y641N/Y641F/Y641H/Y641S) on Disease Free Survival of Patients with Diffuse Large B-Cell Lymphoma

18F-Fluorodeoxyglucose Positron Emission Tomography Versus Bone Marrow Biopsy for the Evaluation of Bone Marrow Infiltration in Newly Diagnosed Lymphoma Patients: Real-World Clinical Management of Patients at the National Cancer Institute, México

Report of 5 Cases of Extramedullary Myeloma with Central Nervous System Involvement Treated with a Combination of Carfilzomib/Thalidomide/Dexamethasone As a First Line Treatment at a Single Institution in Mexico

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Local Experience with Autologous Stem Cell Transplant in Multiple Myeloma at a Public Institution (Instituto Nacional de Cancerologia)

Impact Of a Federal Program On response Rate & Survival, In a Cohort Of Patients With Diffuse Large B- Cell Lymphoma. Analysis In a Single National Reference Institution In Mexico

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Hydralazine + Magnesium Valproate as Epigenetic Treatment for Myelodysplastic Syndrome (MDS). Preliminary Results of a Phase II Trial.

The Age of Mexican Patients with Chronic Myeloid Leukemia (CML) Ph+ Is Quite Younger Than the Reported in USA and European Series.

Importance of the Polymorphisms of the Thiopurine S-Methyltransferase Gene (TMPT) Determination in Mexican Mestizo Patients with Acute Lymphoblastic Leukemia (ALL).

Imatinib Alone (IA) Vs. Imatinib + Ara-C (IMAC): A Randomized Phase III Clinical Trial for the Treatment of Early Phase (EP) Chronic Myeloid Leukemia (CML) Ph+. Preliminary Report of Mexican Cooperative Leukemia Group (GRUMELA).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only